Wuhan Keqian Biology Co Ltd (688526) — Capital Reinvestment Ratio
Wuhan Keqian Biology Co Ltd (688526) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥174.36 Million) in capital expenditures (CN¥11.35 Million). See how leveraged is Wuhan Keqian Biology Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Wuhan Keqian Biology Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Wuhan Keqian Biology Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 688526 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Wuhan Keqian Biology Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see market cap of Wuhan Keqian Biology Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥392.68 Million | CN¥106.94 Million | ▲ +40.2% |
| 2023 | 0.19x | CN¥538.03 Million | CN¥104.50 Million | ▼ -20.0% |
| 2022 | 0.24x | CN¥423.71 Million | CN¥102.85 Million | ▼ -65.6% |
| 2021 | 0.70x | CN¥531.27 Million | CN¥374.45 Million | ▲ +152.7% |
| 2020 | 0.28x | CN¥400.14 Million | CN¥111.60 Million | ▼ -68.6% |
| 2019 | 0.89x | CN¥154.89 Million | CN¥137.74 Million | ▲ +895.7% |
| 2018 | 0.09x | CN¥351.83 Million | CN¥31.42 Million | ▼ -76.6% |
| 2017 | 0.38x | CN¥337.61 Million | CN¥129.11 Million | ▲ +189.7% |
| 2016 | 0.13x | CN¥220.69 Million | CN¥29.13 Million | — |